Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of interleukin-10 analogs for antagonists to treat endotoxin- or superantigen-induced toxicity

Use of interleukin-10 analogs for antagonists to treat endotoxin- or superantigen-induced toxicity

US Patent 5837293 · Granted Nov 17, 1998

Estimated economic value: $115,213,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for achieving therapeutically effective doses of anti-CD47 agents2025
Methods for treating myeloma by achieving therapeutically effective doses of ant2025
Anti-LAG3 antibodies and antigen-binding fragments2024
Ex vivo antibody production2024
Therapeutic anti-CD9 antibody2024
Means and methods for counteracting myeloproliferative or lymphoproliferative di2023
Methods for treating cancer by achieving therapeutically effective doses of anti2023
AML antigens and uses thereof2022
Methods for treating cancer by achieving therapeutically effective doses of anti2022
Anti-LAG3 antibodies and antigen-binding fragments2022
Anti-LAG3 antibodies and antigen-binding fragments2021
Methods for treating cancer by achieving therapeutically effective doses of anti2021